Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, and marketing of generic pharmaceutical formulations in India, the United States, Germany, Brazil, and internationally. It offers products in various therapeutic areas, including cardiovascular, central nervous system, gastrointestinal, women healthcare, diabetology, pain management, gynecology, oncology, and anti-infective, as well as provides vitamins, minerals, and nutrients. The company also provides contract manufacturing services. It has licensing collaborations of Baricitinib, Molnupiravir, and Paxlovid for its Covid portfolio. Torrent Pharmaceuticals Limited was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. The company was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Investments Private Limited.
Earnings for Torrent Pharmaceuticals Limited (TORNTPHARM.NS)
Earnings in 2023 (TTM): $277.38 M
According to Torrent Pharmaceuticals Limited's latest financial reports the company's current earnings (TTM) are $277.38 M. The earnings displayed on this page is the company's Pretax Income.
Earnings history of Torrent Pharmaceuticals Limited
Annual Earnings
| Year | Income Before Tax | Net Income |
|---|---|---|
| 2023 | $277.38 M | $195.33 M |
| 2022 | $217.81 M | $146.85 M |
| 2021 | $144.57 M | $91.65 M |
| 2020 | $179.99 M | $147.63 M |
| 2019 | $139.93 M | $120.84 M |
| 2018 | $66.24 M | $51.45 M |
| 2017 | $109.79 M | $79.97 M |
| 2016 | $128.32 M | $110.09 M |
| 2015 | $278.76 M | $203.12 M |
| 2014 | $110.83 M | $88.56 M |
| 2013 | $99.53 M | $78.29 M |
| 2012 | $68.59 M | $51.03 M |
| 2011 | $42.29 M | $33.5 M |
| 2010 | $40.41 M | $31.86 M |
| 2009 | $40.95 M | $27.26 M |
| 2008 | $22.66 M | $21.74 M |
| 2007 | $17.58 M | $15.88 M |
| 2006 | $12.86 M | $11.03 M |
| 2005 | $9.16 M | $6 M |
| 2004 | $6.71 M | $5.75 M |